Johnson & Johnson vs Legend Biotech Corporation — Stock Comparison

JNJ
Johnson & Johnson
$227.19
▼ 1.16%
vs
LEGN
Legend Biotech Corporation
$23.59
▲ 0.30%
Q·Score Winner
Johnson & Johnson
JNJ7.1/10vs 5.9/10

Q·Score Breakdown

7.1
Bullish
Overall
5.9
Neutral
9.3
Quality
0.2
6.5
Health
7.6
5.1
Growth
5.5
7.3
Valuation
9.7
6.5
Sentiment
8.3
JNJ

High-quality business with 26% return on equity and 22% profit margins.

earnings contracting 53% year-over-year.

LEGN

Consensus analyst target of $57.23 is 143% above current price.

currently unprofitable (-29% margin).

Analyst Consensus

BUY
Target $252.42 (+11.1%)
24 analysts
BUY
Target $57.23 (+142.6%)
16 analysts

Fundamentals

JNJ
LEGN
26.3×
Trailing P/E
17.9×
Forward P/E
20.5×
21.8%
Profit Margin
-28.8%
68.0%
Gross Margin
20.0%
26.4%
ROE
-29.1%
9.9%
Revenue Growth
64.2%
-52.9%
Earnings Growth
0.33
Beta
0.08
Price / Book
$546.9B
Market Cap
$4.4B
$146 – $252
52-Week Range
$16 – $45

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →